Clover Health Investments CLOV Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Clover Health Investments's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Clover Health Investments's stock-based comp?
- Clover Health Investments (CLOV) reported stock-based comp of $12.27M in Q1 2026.
- How has Clover Health Investments's stock-based comp changed year-over-year?
- Clover Health Investments's stock-based comp decreased by 53.6% year-over-year, from $26.44M to $12.27M.
- What is the long-term trend for Clover Health Investments's stock-based comp?
- Over 4 years (2021 to 2025), Clover Health Investments's stock-based comp has grown at a -10.8% compound annual growth rate (CAGR), from $163.72M to $103.66M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.